Ms. Burt chose the Valley breast surgery team after carefully researching her treatment options for DCIS (ductal carcinoma in situ), a diagnosis that is often debated among clinicians as to whether it should be
classified as breast cancer at all.
Not exact matches
About 15 to 20 % of
breast cancers are
classified as «triple negative,» so called because these tumors do not express three key proteins that are biomarkers and / or drug targets for
breast cancer: the estrogen receptor, the progesterone receptor, and HER2 (a member of the epidermal growth factor receptor family).
Tumors were evaluated by a pathologist at the microscopic level to
classify them
as either classic or pleomorphic lobular
breast cancer.
Given those findings, the researchers say, about 46 percent of women with
breast cancer who are
classified as high risk based on clinical factors might not need chemo.
Breast cancers are
classified as ER - positive or ER - negative according to whether tumors are found to contain estrogen receptors.
Now, all
breast cancers are
classified as estrogen - receptor positive or negative, an important guide to prognosis and therapy, and medications, such
as tamoxifen, that can block the effects of estrogen have become important tools in the treatment and possible prevention of
breast cancer.
After adjusting for common factors that influence
breast cancer risk, Henderson and colleagues found that women whose mammograms were
classified as false - positive who were referred for additional imaging had a 39 percent increased chance of developing subsequent
breast cancer during the 10 - year follow - up period, compared with women with a true - negative result.
Women whose mammograms were
classified as false - positive but were referred for a
breast biopsy had a 76 percent increased chance of developing subsequent
breast cancer compared with women with a true - negative result.
Thyroid, lung and
breast cancers can be
classified as indolent,
as can many cases of prostate
cancer.
Approximately 70 percent of
breast cancers are
classified as estrogen receptor - positive — where the
cancer is fueled by the hormone estrogen.
At one time, there was concern that flaxseed's lignans,
classified as phytoestrogens could raise the risk of
breast cancers that are fueled by high levels of estrogen.